1987/1988/1989/1990/1991/1992/1993/1994/1995/1996/1997/1998/1999/2000/2001/2002/2003/2004/2005/2006/2007/2008/2009/ 2010/2011/2012/2013/2014/2015/2016/2017/2018/2019/2020/

261. Twarog C, Liu K, O’Brien PJ, Dawson KA, Fattal E, Illel B, Brayden DJ.  A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10). Eur J Pharm Biopharm. 2020 Jul;152:95-107 –
260. Yu Z, Reynaud F, Lorscheider M, Tsapis N, Fattal E.Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis. Wires Nanomedicien and Nanobiotechnology, 2020 –
259. Costamagna F, Hillaireau H, Vergnaud-Gauduchon J, Clarisse D, Jamgotchian L., Loreau O, Denis S, Gravel E, Doris E, Fattal E.Nanotoxicology at the particle/micelle frontier: influence of core-polymerization on the intracellular distribution, cytotoxicity and genotoxicity of polydiacetylene micelles. Nanoscale, 2020, 12, 2452-2463 –
258. Pandolfi L, Frangipane V, Bocca C, Marengo A, Tarro Genta E, Bozzini S, Morosini M, D’Amato M, Vitulo S, Monti M, Comolli G, Scupoli MT, Fattal E, Arpicco S, Meloni F. Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells. Molecules. 2019 (18). pii: E3291.
257. Pinto Carneiro S, Moine L, Tessier B, Nicolas V, Henrique dos Santos OD, Fattal E, Poly(malic acid) biodegradable nanoconjugate for efficient intracellular delivery. Precision Nanomedicine 2019 2(3):303-317 –
256. Alshaer W, Zraikat M, Amer A, Nsairat H, Lafi Z, Alqudah D, Al Qadi E, Alsheleh T, Odeh F, Alkaraki A, Zihlif M, Bustanji Y, Fattal E, Awidi A, Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma, RSC Advances, 2019, 9, 30976-30988
255. Albert C, Beladjine M, Tsapis N, Fattal E, Agnely F, Huang N. Pickering emulsions: Preparation processes, key parameters governing their properties and potential for pharmaceutical applications. J Control Release. 2019, 309:302-332.
254. Leng D, Kissi EO, Löbmann K, Thanki K, Fattal E, Rades T, Foged C, Yang M. Design of inhalable solid dosage forms of Budesonide and Theophylline for pulmonary combination therapy. AAPS PharmSciTech. 2019 Mar 7;20(3):137. doi: 10.1208/s12249-019-1344-9. –
253. Lorscheider M, Tsapis N, Simon-Vasquez R, Guiblin N, Ghermani N, Reynaud F, Canioni R, Abreu S, Chaminade P, Fattal E. Nanoscale lipophilic prodrugs of dexamethasone with enhanced pharmacokinetics. Molecular Pharmaeutics 2019, 16(7):2999-3010 –
252. Gazzano E, Buondonno I, Marengo A, Rolando B, Chegaev K, Kopecka J, Saponara S, Sorge M, Hattinger CM, Gasco A, Fruttero R, Brancaccio M, Serra M, Stella B, Fattal E, Arpicco S, Riganti C. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts. Cancer Letters 2019 Apr 29;456:29-39. –
251. Twarog C, Fattah S, Heade J., Maher S., Fattal E., Brayden DJ. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10). Pharmaceutics 2019, 11(2), 78 –
250. Deschamps F, Isoardo T, Denis S, Tsapis N, Tselikas L, Nicolas V, Paci A, Fattal E, de Baere T, Huang N, Moine L. Biodegradable Pickering emulsions of Lipiodol for liver trans-arterial chemo-embolization. Acta Biomaterialia, 2019, 87, 177-186 –
249. Mura S, Fattal E, Nicolas J.From Poly(Alkyl Cyanoacrylate) to Squalene as Core Material to Design Nanomedicines.  Journal of Drug Targeting –
248. Barillet S., Fattal E., Mura S., Tsapis N., Pallardy M., Hillaireau H., Kerdine-Römer S., Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation. Nanotoxicology –
247. Chvatal A,  Ambrus R, Party P, Katona G, Jójárt-Laczkovich O, Szabó-Révész P,  Fattal E, Tsapis N, Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery. International Journal of Pharmaceutics, 2019, 559, 68-75 –
246. Pallotta A., Clarot I., Sobocinski  J., Fattal E., Boudier A., Nanotechnologies for Medical Devices: Potentialities and Risks. ACS Applied Bio  Materials 2019, 2 (1), pp 1 –13 –
245. Lorscheider M., Tsapis N., Ur-Rehman M., Gaudin F., Stolfa I., Abreu S., Mura S., Chaminade P., Espeli M., Fattal E., Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. Journal of Controlled Release, 2019, 296 179-189 –
244. Marengo A., Forciniti S., Dando I., Elisa DallaPozza E., Stella B., Tsapis N. Yagoubi N., Fanelli G., Fattal E., Heeschen C., Palmieri M., Arpicco S. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate‑copper complex loaded into hyaluronic acid decorated liposomes. Biochimica et Biophysica Acta (BBA) – General Subjects 1863(1); 61-72, 2019
243. Albert C, Huang N, Tsapis N, Geiger S, Rosilio V, Mekhloufi G, Chapron D, Robin B, Beladjine M, Nicolas V, Fattal E, Agnely F.Bare and Sterically Stabilized PLGA Nanoparticles for the Stabilization of Pickering Emulsions. Langmuir. 2018 Nov 20;34(46):13935-13945 –
242. Alshaer W., Hillaireau H., Fattal E., Aptamer-guided nanomedicines for anticancer drug delivery. Advanced drug delivery reviews, 134, 122-137;2018 –
241. Giacalone G., Tsapis N., Mousnier L., Chacun H., Fattal E. PLA-PEG nanoparticles improve the anti-inflammatory effect of Rosiglitazone on macrophages by enhancing drug uptake compared to free Rosiglitazone. Materials , 11(10), 1845, 2018 –
240. Sauvage F, Fattal E, Al-Shaer W, Denis S, Brotin E, Denoyelle C, Blanc-Fournier C, Toussaint B, Messaoudi S, Alami M, Barratt G, Vergnaud-Gauduchon J. Antitumor activity of nanoliposomes encapsulating the novobiocin analogue 6BrCaQ in a triple-negative breast cancer model in mice. Cancer Letters -432, 103-111, 2018
239. Deriu M.A., Tsapis N., Noiray M., Grasso G., El Brahmi N., Mignani S, Majoral J.P., Fattal E. Danani A. Elucidating the Role of Surface Chemistry on Cationic Phosphorus Dendrimer-siRNA Complexation. Nanoscale – 10, 10952-10962, 2018 –
238. Alshaer, W., Hillaireau, H., Vergnaud, J., Mura S., Deloménie C., Sauvage F., Ismail S., Fattal, E., Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model. Journal of Controlled Release – 271, 198-106, 2018
237. Tortolano L., Saunier J., Hammami S., Manerlax K., Matmati H., Do B., Jubeli E., Fattal E., Yagoubi N. Restructuration kinetics of amphiphilic intraocular lenses during aging. Colloids and Surface B, 161, (1), 20-432, 2018 –
236. Leng D., Thanki K., Fattal E., Foged C., Yang M. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach. International Journal of Pharmaceutics 548)(2),  740-746, 2018 –
235. N’Guessan A., Fattal E., Chapron D., Gueutin C., Koffi A., Tsapis N., Dexamethasone palmitate large porous particles: a controlled release formulation for lung delivery of corticosteroids. European Journal of Pharmaceutical Sciences, 113, 185-192, 2018 –
234. Teixeira HF, Bruxel F, Fraga M, Schuh RS, Zorzi GK, Matte U, Fattal E. Cationic nanoemulsions as nucleic acids delivery systems. International Journal of Pharmaceutics 534, (1–2), 356-367, 2017 –
233. Boissenot T., Bordat A., Larrat B., Varna M., Chacun H., Paci A., Poinsignon V., Fattal E., Tsapis N., Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules. Journal of Controlled Release, 264, 219-227, 2017 –
232. Deschamps F, Moine L, Isoardo T, Tselikas L, Paci A, Mir LM, Huang N, Fattal E, de Baère T. Parameters for stable water-in-oil lipiodol emulsion for liver trans-arterial chemo-embolization. CardioVascular and Interventional Radiology 40, (12), 1927–1932, 2017 –
231. Bohr A, Tsapis N, Andreana I, Chamarat A, Foged C, Delomenie C, Noiray M, El Brahmi N, Majoral JP, Mignani S, Fattal E. Anti-inflammatory effect of anti-TNF-α siRNA cationic phosphorous dendrimers nanocomplexes administered intranasally in a murine acute lung injury model. Biomacromolecules, 18 (8), 2379–2388, 2017 –
230. Cosco D, Tsapis N, Nascimento TL, Fresta M, Chapron D, Taverna M, Arpicco S, Fattal E. Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate. Colloids and Surfaces B: Biointerfaces 158C, 119-126, 2017 –
229. Gokce EH, Tuncay Tanrıverdi S, Eroglu I, Tsapis N, Gokce G, Tekmen I, Fattal E, Ozer O. Wound healing effects of collagen-laminin dermal matrix impregnated with resveratrol loaded hyaluronic acid-DPPC microparticles in diabetic rats. European journal of pharmaceutics and biopharmaceutics, 119, 17-27, 2017 –
228. Manconi M., Manca M. L., Valenti D., Escribano E., Hillaireau H., Fadda A. M., Fattal E., Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin. International Journal of Pharmaceutics 1(15), 203-210, 2017 –
227. Sauvage F, Messaoudi S, Fattal E, Barratt G, Vergnaud-Gauduchon J. Heat shock proteins and cancer: How can nanomedicine be harnessed? Journal of Controlled Release, 248:133-143, 2017 –
226. Martens TF, Peynshaert K, Nascimento TL, Fattal E, Karlstetter M, Langmann T, Picaud S, Demeester J, De Smedt SC, Remaut K, Braeckmans K. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy. European Journal of Pharmaceutical Sciences 103:27-35, 2017 –
225. Grivès S, Phan G, Bouvier-Capely C, Suhard D, Rebière F, Agarande M, Fattal E. Compared in vivo efficiency of nanoemulsions unloaded and loaded with calixarene and soapy water in the treatment of superficial wounds contaminated by uranium. Chemico-Biological Interactions, 267:33–39, 2017 –
224. Ruge C., Hillaireau H., Grabowski N., Beck-Broichsitter M., Canadas O., Tsapis N., Casals C., Nicolas J., Fattal, E. Pulmonary surfactant protein a – mediated enrichment of surface-decorated polymeric nanoparticles in alveolar macrophages. Molecular Pharmaceutics, 13(12):4168-4178, 2016 –
223. Boissenot T, Fattal E, Bordat A, Houvenagel S, Valette J, Chacun H, Gueutin C, Tsapis N. Paclitaxel-Loaded PEGylated Nanocapsules of Perfluorooctyl Bromide as Theranostic Agents. European Journal of Pharmaceutics and Biopharmaceutics. 108:136-144, 2016 –
222. Leite Nascimento T., Hillaireau H., Vergnaud J.,  Rivano M., Deloménie C., Courilleau D., Arpicco S., Soo Suk J., Hanes J., Fattal E. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. International Journal of Pharmaceutics. 514(1):103-111, 2016 –
221. Boissenot T., Bordat A., Fattal E., Tsapis N. Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications. Journal of Controlled Release, 241, 10, 144–163, 2016 –
220. Diou O, Brûlet A, Pehau-Arnaudet G, Morvan E, Berti R, Astafyeva K, Taulier N, Fattal E, Tsapis N. PEGylated nanocapsules of perfluorooctyl bromide: Mechanism of formation, influence of polymer concentration on morphology and mechanical properties. Colloids and Surfaces B: biointerfaces, 146:762-769, 2016 –
219. Leite Nascimento T., Hillaireau H., Vergnaud J., Fattal E. Lipid based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs. Nanomedicine, 12(1):135-46, 2016 –
218. Dosio F., Arpicco S., Stella B., Fattal E. Hyaluronic acid for anticancer drug and nucleic acid delivery Advanced Drug Delivery Reviews, 97, 204–236, 2016 –
217. Ruge C., Bohr A., Beck-Broichsitter M., Nicolas V., Tsapis N., Fattal E. Disintegration of nano-embedded microparticles after deposition on mucus: a mechanistic study. Colloids and Surfaces B: biointerfaces, 139, 219–227, 2016 –
216. Santiago, L, Hillaireau, H., Grabowski, N., Mura, S., Nascimento, T., Dufort, S., Coll, J-L, Tsapis, N., Fattal, E., Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles Nanotoxicology, 10(3):292-302, 2016 –
215.  Grabowski, N., Hillaireau, H., Vergnaud, J., Nicolas V., Tsapis, N., Kerdine-Romer S., Fattal, E., Surface-modified biodegradable nanoparticles’ impact on cytotoxicity and inflammation response on a co-culture of lung epithelial cells and human-like macrophages. Journal of Biomedical Nanotechnology, 12, 135-146, 2016 –
214. Nascimento T L, Hillaireau H, Fattal E. Noiray M., Bourgaux C., Arpicco S., Pehau-Arnaudet G., Taverna M., Cosco D., Tsapis N., Fattal E. Supramolecular organization and siRNA binding of hyaluronic acid-coated lipoplexes for targeted delivery to CD44 receptor. Langmuir, 31(41):11186-11194, 2015 –
213. Pham D., Fattal E., Tsapis N., Pyrazinamide-loaded poly(lactide-co-glycolide) nanoparticles: Optimization by experimental design. Journal of Drug Delivery Science and Technology, 30, 384-390, 2015 –
212. Reynaud F., Tsapis N., Guterres S.S., Pohlmann A.R., Fattal E., Pectin beads loaded with chitosan-iron microspheres for specific colonic adsorption of ciprofloxacin. Journal of Drug Delivery Science and Technology, 30, 494-500, 2015 –
211. Fattal E, Tsapis N, Phan G., Novel drug delivery systems for actinides (uranium and plutonium) decontamination agents. Advanced Drug Delivery Reviews, 90, 40-54 2015 –
210. Pham DD, Grégoire N, Couet W, Gueutin C, Fattal E, Tsapis N., Pulmonary delivery of pyrazinamide-loaded large porous particles. European Journal of Pharmaceutics and Biopharmaceutics, 94, 241-250, 2015 –
209. Giacalone, G., Hillaireau, H., Fattal, E., Improving bioavailability and biodistribution of anti-HIV chemotherapy European Journal of Pharmaceutical Sciences. 75: 40-53, 2015 –
208. Novell, A., Al Sabbagh, C., Escoffre, J.M., Gaillard, C., Tsapis, N., Fattal, E., Bouakaz, A., Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes. Int J Hyperthermia. 31:349-358, 2015 –
207. Grivès, S., Phan, G., Morat, G., Suhard, D., Rebière, F., Fattal, E., Ex vivo uranium decontamination efficiency on wounded skin and in vitro skin toxicity of a calixarene-loaded nanoemulsion. Journal of Pharmaceutical Sciences. 104(6):2008-2017, 2015 –
206. Eroğlu İ, Gökçe EH, Tsapis N, Tanrıverdi ST, Gökçe G, Fattal E, Özer Ö Evaluation of characteristics and in vitro antioxidant properties of RSV loaded hyaluronic acid-DPPC microparticles as a wound healing system. Colloids and Surface B Biointerfaces,126:50-7, 2015 –
205. Pham D, Fattal E, Tsapis N. Pulmonary drug delivery systems for tuberculosis treatment. International Journal of Pharmaceutics. 478(2):517-29, 2015 –
204. Cosco D, Paolino D, Angelis FD, Cilurzo F, Celia C, Marzio LD, Russo D, Tsapis N, Fattal E, Fresta M. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. European Journal of Pharmaceutics and Biopharmaceutics 89:30-9, 2015 –
203. Grabowski N, Hillaireau H, Vergnaud J, Tsapis N1, Pallardy M, Kerdine-Römer S, Fattal E. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. International Journal of Pharmaceutics. 482(1-2):75-83, 2015 –
202. Cosco, D., Fattal, E., Fresta, M., Tsapis N., Perfluorocarbon-loaded micro and nanosystems for medical imaging: a state of the art. Journal of Fluorine Chemistry. 171:18-26, 2015 –
201. Al Sabbagh, C, Tsapis, N, Novell, A., Calleja-Gonzalez, P., Escoffre, JM, Bouakaz A, Chacun, H., Denis, S, Vergnaud, J, Gueutin, C, Fattal, E, Formulation and Pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil. Pharmaceutical Research, 32(5):1585-603, 2015 –
200. Alshaer, W., Hillaireau, H., Vergnaud, J.,Ismail S., Fattal, E., Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells. Bioconjugate Chemistry, 26 (7), 1307–1313, 2015 –
199. Fattal, E., Grabowski, N., Mura, S., Vergnaud, J., Tsapis, N., Hillaireau, H., Lung Toxicity of Biodegradable Nanoparticles. Journal of Biomedical Nanotechnology, 10(10), 2852-2864, 2014 –
198. Fattal, E., Tsapis, N., Nanomedicine technology: current achievements and new trends. Clinical and Translational Imaging, 2(1), 77-87, 2014 –
197. Belhomme-Henry, C., Phan, G., Huang, N., Bouvier, C., Rebiere, F., Agarande, M., Fattal, E., Texturing formulations for uranium skin decontamination. Pharmaceutical Development and Technology, 19(6), 692-701, 2014 –
196. Diou, O., Fattal, E., Delplace, V., Mackiewicz, N., Nicolas, J., Meriaux, S., Valette, J., Robic, C., Tsapis, N., RGD decoration of PEGylated polyester nanocapsules of perfluorooctyl bromide for tumor imaging: influence of pre or post-functionalization on capsule morphology. European Journal of Pharmaceutics and Biopharmaceutics, 87(1), 170-177, 2014 –
195. Bol, L., Galas, J.C., Hillaireau, H., Le Potier, I., Nicolas, V., Haghiri-Gosnet, A.M., Fattal, E., Taverna, M., A microdevice for parallelized pulmonary permeability studies. Biomedical Microdevices, 16(2), 277-285, 2014 –
194. Jafari, S., Diou, O., Mamou, J., Renault, G., Fattal, E., Tsapis, N., Bridal, S.L., High-frequency (20 to 40 MHz) acoustic response of liquid-filled nanocapsules. IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 61(1), 5-15, 2014 –
193. Bruxel, F., Bochot, A., Diel, D., Wild, L., Carvalho, E.L., Cojean, S., Loiseau, P.M., Fattal, E., Teixeira, H.F., Adsorption of antisense oligonucleotides targeting malarial topoisomerase II on cationic nanoemulsions optimized by a full factorial design. Current Topics in Medicinal Chemistry, 14(9), 1161-1171, 2014 –
192. Mousnier, L., Huang, N., Morvan, E., Fattal, E., Tsapis, N., Influence of polymer end-chemistry on the morphology of perfluorohexane polymeric microcapsules intended as ultrasound contrast agents. International Journal of Pharmaceutics, 471(1-2), 10-17, 2014 –
191. Giacalone, G., Hillaireau, H., Capiau, P., Chacun, H., Reynaud, F., Fattal, E., Stabilization and cellular delivery of chitosan-polyphosphate nanoparticles by incorporation of iron. Journal of Controlled Release, 194, 211-219, 2014 –
190. Ismail, S., Alshaer, W., Ababneh, N., Fattal, E., Aptamers: Promising Molecules for Cancer Stem Cell Targeting. Journal of Molecular and Genetic Medicine, 7(90), 1-10, 2013 –
189. Hamoudi, M.C., Saunier, J., Gueutin, C., Fattal, E., Bochot, A., Beads made of alpha-cyclodextrin and soybean oil: the drying method influences bead properties and drug release. Drug Development and Industrial Pharmacy, 39(9), 1306-1314, 2013 –
188. Gomez-Gaete, C., Bustos, G.L., Godoy, R.R., Saez, C.K., Novoa, G.P., Fernandez, E.M., Tsapis, N., Fattal, E., Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles. Drug Development and Industrial Pharmacy, 39(2), 310-320, 2013 –
187. Pham, D.D., Fattal, E., Ghermani, N., Guiblin, N., Tsapis, N., Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: avoiding crystal growth using excipients. International Journal of Pharmaceutics, 454(2), 668-677, 2013 –
186. Tobar-Grande, B., Godoy, R., Bustos, P., von Plessing, C., Fattal, E., Tsapis, N., Olave, C., Gomez-Gaete, C., Development of biodegradable methylprednisolone microparticles for treatment of articular pathology using a spray-drying technique. International Journal of Nanomedicine, 82065-2076, 2013 –
185. Grabowski, N., Hillaireau, H., Vergnaud, J., Santiago, L.A., Kerdine-Romer, S., Pallardy, M., Tsapis, N., Fattal, E., Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. International Journal of Pharmaceutics, 454(2), 686-694, 2013 –
184. Arpicco, S., Lerda, C., Dalla Pozza, E., Costanzo, C., Tsapis, N., Stella, B., Donadelli, M., Dando, I., Fattal, E., Cattel, L., Palmieri, M., Hyaluronic acid-coated liposomes for active targeting of gemcitabine. European Journal of Pharmaceutics and Biopharmaceutics, 85(3), 373-380, 2013 –
183. Phan, G., Semili, N., Bouvier-Capely, C., Landon, G., Mekhloufi, G., Huang, N., Rebiere, F., Agarande, M., Fattal, E., Calixarene cleansing formulation for uranium skin contamination. Health Physics, 105(4), 382-389, 2013 –
182. Ababneh, N., Alshaer, W., Allozi, O., Mahafzah, A., El-Khateeb, M., Hillaireau, H., Noiray, M., Fattal, E., Ismail, S., In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker. Nucleic Acid Therapeutics, 23(6), 401-407, 2013 –
181. Giacalone, G., Bochot, A., Fattal, E., Hillaireau, H., Drug-Induced Nanocarrier Assembly as a Strategy for the Cellular Delivery of Nucleotides and Nucleotide Analogues. Biomacromolecules, 14(3), 737-742, 2013 –
180. Dalla Pozza, E., Lerda, C., Costanzo, C., Donadelli, M., Dando, I., Zoratti, E., Scupoli, M.T., Beghelli, S., Scarpa, A., Fattal, E., Arpicco, S., Palmieri, M., Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Biochimica et Biophysica Acta, 1828(5), 1396-1404, 2013 –
179. Arpicco, S., De Rosa, G., Fattal, E., Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells. Journal of drug delivery, 2013860780-860780, 2013 –
178. Diou, O., Tsapis, N., Giraudeau, C., Valette, J., Gueutin, C., Bourasset, F., Zanna, S., Vauthier, C., Fattal, E., Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI. Biomaterials, 33(22), 5593-5602, 2012 –
177. Xiong, B., Pallandre, A., le Potier, I., Audebert, P., Fattal, E., Tsapis, N., Barratt, G., Taverna, M., Electrophoretic mobility measurement by laser Doppler velocimetry and capillary electrophoresis of micrometric fluorescent polystyrene beads. Analytical Methods, 4(1), 183-189, 2012 –
176. Reul, R., Tsapis, N., Hillaireau, H., Sancey, L., Mura, S., Recher, M., Nicolas, J., Coll, J.-L., Fattal, E., Near infrared labeling of PLGA for in vivo imaging of nanoparticles. Polymer Chemistry, 3(3), 694-702, 2012 –
175. Nascimento, T.L., Hillaireau, H., Fattal, E., Nanoscale particles for lung delivery of siRNA. Journal of Drug Delivery Science and Technology, 22(1), 99-108, 2012 –
174. Menard, N., Tsapis, N., Poirier, C., Arnauld, T., Moine, L., Lefoulon, F., Pean, J.-M., Fattal, E., Drug solubilization and in vitro toxicity evaluation of lipoamino acid surfactants. International Journal of Pharmaceutics, 423(2), 312-320, 2012 –
173. Menard, N., Tsapis, N., Poirier, C., Arnauld, T., Moine, L., Gignoux, C., Lefoulon, F., Pean, J.-M., Fattal, E., Novel Surfactants with Diglutamic Acid Polar Head Group: Drug Solubilization and Toxicity Studies. Pharmaceutical Research, 29(7), 1882-1896, 2012 –
172. Hamoudi, M.C., Bourasset, F., Domergue-Dupont, V., Gueutin, C., Nicolas, V., Fattal, E., Bochot, A., Formulations based on alpha cyclodextrin and soybean oil: an approach to modulate the oral release of lipophilic drugs. Journal of Controlled Release, 161(3), 861-867, 2012 –
171. Dufay Wojcicki, A., Hillaireau, H., Nascimento, T.L., Arpicco, S., Taverna, M., Ribes, S., Bourge, M., Nicolas, V., Bochot, A., Vauthier, C., Tsapis, N., Fattal, E., Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. Journal of Controlled Release, 162(3), 545-552, 2012 –
170. Diou, O., Tsapis, N., Fattal, E., Targeted nanotheranostics for personalized cancer therapy. Expert Opinion on Drug Delivery, 9(12), 1475-1487, 2012 –
169. Bochot, A., Fattal, E., Liposomes for intravitreal drug delivery: A state of the art. Journal of Controlled Release, 161(2), 628-634, 2012 –
168. Reynaud, F., Tsapis, N., Deyme, M., Vasconcelos, T.G., Gueutin, C., Guterres, S.S., Pohlmann, A.R., Fattal, E., Spray-dried chitosan-metal microparticles for ciprofloxacin adsorption: Kinetic and equilibrium studies. Soft Matter, 7(16), 7304-7312, 2011 –
167. Trichard, L., Chaminade, P., Grossiord, J.L., Le Bas, G., Huang, N., Durand, D., Fattal, E., Bochot, A., Beads made of alpha-cyclodextrin and vegetable oils: oil composition and physicochemical properties influence bead feasibility and properties. Journal of Drug Delivery Science and Technology, 21(2), 189-194, 2011 –
166. Bruxel, F., Cojean, S., Bochot, A., Teixeira, H., Bories, C., Loiseau, P.M., Fattal, E., Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II. International Journal of Pharmaceutics, 416(2), 402-409, 2011 –
165. Hamoudi, M., Fattal, E., Gueutin, C., Nicolas, V., Bochot, A., Beads made of cyclodextrin and oil for the oral delivery of lipophilic drugs: in vitro studies in simulated gastro-intestinal fluids. International Journal of Pharmaceutics, 416(2), 507-514, 2011 –
164. Cruz, L., Fattal, E., Tasso, L., Freitas, G.C., Carregaro, A.B., Guterres, S.S., Pohlmann, A.R., Tsapis, N., Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery. Journal of Controlled Release, 152(3), 370-375, 2011 –
163. Spagnul, A., Bouvier-Capely, C., Phan, G., Landon, G., Tessier, C., Suhard, D., Rebiere, F., Agarande, M., Fattal, E., Ex vivo decrease in uranium diffusion through intact and excoriated pig ear skin by a calixarene nanoemulsion. European Journal of Pharmaceutics and Biopharmaceutics, 79(2), 258-267, 2011 –
162. Sandolo, C., Pechine, S., Le Monnier, A., Hoys, S., Janoir, C., Coviello, T., Alhaique, F., Collignon, A., Fattal, E., Tsapis, N., Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile. European Journal of Pharmaceutics and Biopharmaceutics, 79(3), 566-573, 2011 –
161. Menard, N., Tsapis, N., Poirier, C., Arnauld, T., Moine, L., Lefoulon, F., Pean, J.M., Fattal, E., Physicochemical characterization and toxicity evaluation of steroid-based surfactants designed for solubilization of poorly soluble drugs. European Journal of Pharmaceutical Sciences, 44(5), 595-601, 2011 –
160. Mura, S., Hillaireau, H., Nicolas, J., Le Droumaguet, B., Gueutin, C., Zanna, S., Tsapis, N., Fattal, E., Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. International Journal of Nanomedicine, 62591-2605, 2011 –
159. Mura, S., Hillaireau, H., Nicolas, J., Kerdine-Roemer, S., Le Droumaguet, B., Delomenie, C., Nicolas, V., Pallardy, M., Tsapis, N., Fattal, E., Biodegradable Nanoparticles Meet the Bronchial Airway Barrier: How Surface Properties Affect Their Interaction with Mucus and Epithelial Cells. Biomacromolecules, 12(11), 4136-4143, 2011 –
158. Khoder, M., Tsapis, N., Fattal, E., Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence. Journal of Drug Delivery Science and Technology, 20(6), 407-418, 2010 –
157. Urbinati, G., Marsaud, V., Plassat, V., Fattal, E., Lesieur, S., Renoir, J.M., Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. International Journal of Pharmaceutics, 397(1-2), 184-193, 2010 –
156. Urbinati, G., Audisio, D., Marsaud, V., Plassat, V., Arpicco, S., Sola, B., Fattal, E., Renoir, J.M., Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model. Pharmaceutical Research, 27(2), 327-339, 2010 –
155. Spagnul, A., Bouvier-Capely, C., Phan, G., Rebiere, F., Fattal, E., Calixarene-Entrapped Nanoemulsion for Uranium Extraction from Contaminated Solutions. Journal of Pharmaceutical Sciences, 99(3), 1375-1383, 2010 –
154. Spagnul, A., Bouvier-Capely, C., Phan, G., Rebiere, F., Fattal, E., A new formulation containing calixarene molecules as an emergency treatment of uranium skin contamination. Health Physics, 99(3), 430-434, 2010 –
153. Spagnul, A., Bouvier-Capely, C., Adam, M., Phan, G., Rebiere, F., Fattal, E., Quick and efficient extraction of uranium from a contaminated solution by a calixarene nanoemulsion. International Journal of Pharmaceutics, 398(1-2), 179-184, 2010 –
152. Khoder, M., Tsapis, N., Domergue-Dupont, V., Gueutin, C., Fattal, E., Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. European Journal of Pharmaceutical Sciences, 41(2), 281-288, 2010 –
151. Giraudeau, C., Flament, J., Marty, B., Boumezbeur, F., Meriaux, S., Robic, C., Port, M., Tsapis, N., Fattal, E., Giacomini, E., Lethimonnier, F., Le Bihan, D., Valette, J., A New Paradigm for High-Sensitivity F-19 Magnetic Resonance Imaging of Perfluorooctylbromide. Magnetic Resonance in Medicine, 63(4), 1119-1124, 2010 –
150. Fritsch, P., Serandour, A.L., Gremy, O., Phan, G., Tsapis, N., Fattal, E., Benech, H., Deverre, J.R., Poncy, J.L., Structure of a single model to describe plutonium and americium decorporation by dtpa treatments. Health Physics, 99(4), 553-559, 2010 –
149. Diaz-Lopez, R., Tsapis, N., Santin, M., Bridal, S.L., Nicolas, V., Jaillard, D., Libong, D., Chaminade, P., Marsaud, V., Vauthier, C., Fattal, E., The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. Biomaterials, 31(7), 1723-1731, 2010 –
148. Diaz-Lopez, R., Tsapis, N., Fattal, E., Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and F-19-MRI. Pharmaceutical Research, 27(1), 1-16, 2010 –
147. Chenal, M., Mura, S., Marchal, C., Gigmes, D., Charleux, B., Fattal, E., Couvreur, P., Nicolas, J., Facile Synthesis of Innocuous Comb-Shaped Polymethacrylates with PEG Side Chains by Nitroxide-Mediated Radical Polymerization in Hydroalcoholic Solutions. Macromolecules, 43(22), 9291-9303, 2010 –
146. Taetz, S., Bochot, A., Surace, C., Arpicco, S., Renoir, J.M., Schaefer, U.F., Marsaud, V., Kerdine-Roemer, S., Lehr, C.M., Fattal, E., Hyaluronic Acid-Modified DOTAP/DOPE Liposomes for the Targeted Delivery of Anti-Telomerase siRNA to CD44-Expressing Lung Cancer Cells. Oligonucleotides, 19(2), 103-115, 2009 –
145. Surace, C., Arpicco, S., Dufay-Wojcicki, A., Marsaud, V., Bouclier, C., Clay, D., Cattel, L., Renoir, J.M., Fattal, E., Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells. Molecular Pharmaceutics, 6(4), 1062-1073, 2009 –
144. Roques, C., Fromes, Y., Fattal, E., Hydrosoluble polymers for muscular gene delivery. European Journal of Pharmaceutics and Biopharmaceutics, 72(2), 378-390, 2009 –
143. Roques, C., Fattal, E., Fromes, Y., Comparison of toxicity and transfection efficiency of amphiphilic block copolymers and polycationic polymers in striated muscles. Journal of Gene Medicine, 11(3), 240-249, 2009 –
142. Roques, C., Bouchemal, K., Ponchel, G., Fromes, Y., Fattal, E., Parameters affecting organization and transfection efficiency of amphiphilic copolymers/DNA carriers. Journal of Controlled Release, 138(1), 71-77, 2009 –
141. Pisani, E., Ringard, C., Nicolas, V., Raphael, E., Rosilio, V., Moine, L., Fattal, E., Tsapis, N., Tuning microcapsules surface morphology using blends of homo- and copolymers of PLGA and PLGA-PEG. Soft Matter, 5(16), 3054-3060, 2009 –
140. Khoder, M., Tsapis, N., Huguet, H., Besnard, M., Gueutin, C., Fattal, E., Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc-pectinate beads. International Journal of Pharmaceutics, 379(2), 251-259, 2009 –
139. Fritsch, P., Serandour, A.L., Gremy, O., Phan, G., Tsapis, N., Abram, M.C., Renault, D., Fattal, E., Benech, H., Deverre, J.R., Poncy, J.L., Simplified Structure of a New Model to Describe Urinary Excretion of Plutonium after Systemic, Liver or Pulmonary Contamination of Rats Associated with Ca-DTPA Treatments. Radiation Research, 171(6), 674-686, 2009 –
138. Fritsch, P., Serandour, A.L., Gremy, O., Le Gall, B., Phan, G., Tsapis, N., Fattal, E., Benech, H., Deverre, J.R., Blanchin, N., Grappin, L., Blanchardon, E., Breustedt, B., Poncy, J.L., Modelling Pu/Am decorporation by DTPA. Radioprotection, 44(4), 431-446, 2009 –
137. Fattal, E., Barratt, G., Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. British Journal of Pharmacology, 157(2), 179-194, 2009 –
136. Diaz-Lopez, R., Tsapis, N., Libong, D., Chaminade, P., Connan, C., Chehimi, M.M., Berti, R., Taulier, N., Urbach, W., Nicolas, V., Fattal, E., Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials, 30(8), 1462-1472, 2009 –
135. Camelo, S., Lajavardi, L., Bochot, A., Goldenberg, B., Naud, M.C., Brunel, N., Lescure, B., Klein, C., Fattal, E., Behar-Cohen, F., de Kozak, Y., Protective Effect of Intravitreal Injection of Vasoactive Intestinal Peptide-Loaded Liposomes on Experimental Autoimmune Uveoretinitis. Journal of Ocular Pharmacology and Therapeutics, 25(1), 9-21, 2009 –
134. Bourgeois, S., Tsapis, N., Honnas, H., Andremont, A., Shakweh, M., Besnard, M., Fattal, E., Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats. Journal of Pharmaceutical Sciences, 97(5), 1853-1863, 2008 –
133. Gomez Gaete, C., Tsapis, N., Silva, L., Bourgaux, C., Fattal, E., Morphology, structure and supramolecular organization of hybrid 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine-hyaluronic acid microparticles prepared by spray drying. European Journal of Pharmaceutical Sciences, 34(1), 12-21, 2008 –
132. Fattal, E., Bochot, A., State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. International Journal of Pharmaceutics, 364(2), 237-248, 2008 –
131. Trichard, L., Fattal, E., Le Bas, G., Duchene, D., Grossiord, J.L., Bochot, A., Formulation and characterisation of beads prepared from natural cyclodextrins and vegetable, mineral or synthetic oils. International Journal of Pharmaceutics, 354(1-2), 88-94, 2008 –
130. Trichard, L., Delgado-Charro, M.B., Guy, R.H., Fattal, E., Bochot, A., Novel beads made of alpha-cyclodextrin and oil for topical delivery of a lipophilic drug. Pharmaceutical Research, 25(2), 435-440, 2008 –
129. Pisani, E., Tsapis, N., Galaz, B., Santin, M., Berti, R., Taulier, N., Kurtisovski, E., Lucidarme, O., Ourevitch, M., Doan, B.T., Beloeil, J.C., Gillet, B., Urbach, W., Bridal, S.L., Fattal, E., Perfluorooctyl Bromide Polymeric Capsules as Dual Contrast Agents for Ultrasonography and Magnetic Resonance Imaging. Advanced Functional Materials, 18(19), 2963-2971, 2008 –
128. Pisani, E., Fattal, E., Paris, J., Ringard, C., Rosilio, V., Tsapis, N., Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: Influence of polymer adsorption at the dichloromethane-water interface. Journal of Colloid and Interface Science, 326(1), 66-71, 2008 –
127. Martini, E., Fattal, E., de Oliveira, M.C., Teixeira, H., Effect of cationic lipid composition on properties of oligonucleotide/emulsion complexes: Physico-chemical and release studies. International Journal of Pharmaceutics, 352(1-2), 280-286, 2008 –
126. Gomez-Gaete, C., Tsapis, N., Silva, L., Bourgaux, C., Besnard, M., Bochot, A., Fattal, E., Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone. European Journal of Pharmaceutics and Biopharmaceutics, 70(1), 116-126, 2008 –
125. Gomez-Gaete, C., Fattal, E., Silva, L., Besnard, M., Tsapis, N., Dexamethasone acetate encapsulation into Trojan particles. Journal of Controlled Release, 128(1), 41-49, 2008 –
124. Diaz-Lopez, R., Libong, D., Tsapis, N., Fattal, E., Chaminade, P., Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector. Journal of Pharmaceutical and Biomedical Analysis, 48(3), 702-707, 2008 –
123. De Rosa, G., De Stefano, D., Laguardia, V., Arpicco, S., Simeon, V., Carnuccio, R., Fattal, E., Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappa B into activated macrophages. European Journal of Pharmaceutics and Biopharmaceutics, 70(1), 7-18, 2008 –
122. Camelo, S., Lajavardi, L., Bochot, A., Goldenberg, B., Naud, M.C., Fattal, E., Behar-Cohen, F., de Kozak, Y., Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics. Ophthalmic Research, 40(3-4), 145-150, 2008 –
121. Breton, P., Larras, V., Roy, D., Sagodira, S., Limal, D., Bonnafous, D., Colin, N., Bru, N., Fattal, E., Couvreur, P., Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics, 68(3), 479-495, 2008 –
120. Bouclier, C., Moine, L., Hillaireau, H., Marsaud, V., Connault, E., Opolon, P., Couvreur, P., Fattal, E., Renoir, J.M., Physicochemical Characteristics and Preliminary in Vivo Biological Evaluation of Nanocapsules Loaded with siRNA Targeting Estrogen Receptor Alpha. Biomacromolecules, 9(10), 2881-2890, 2008 –
119. Gomez-Gaete, C., Tsapis, N., Besnard, M., Bochot, A., Fattal, E., Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. International Journal of Pharmaceutics, 331(2), 153-159, 2007 –
118. Trichard, L., Fattal, E., Besnard, M., Bochot, A., alpha-Cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs. Journal of Controlled Release, 122(1), 47-53, 2007 –
117. Serandour, A.L., Tsapis, N., Gervelas, C., Grillon, G., Frechou, M., Deverre, J.R., Benech, H., Fattal, E., Fritsch, P., Poncy, J.L., Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: A study in rat after lung contamination with different plutonium forms. Radiation Protection Dosimetry, 127(1-4), 472-476, 2007 –
116. Roques, C., Salmon, A., Fiszman, M.Y., Fattal, E., Fromes, Y., Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel. International Journal of Pharmaceutics, 331(2), 220-223, 2007 –
115. Pechine, S., Janoir, C., Boureau, H., Gleizes, A., Tsapis, N., Hoys, S., Fattal, E., Collignon, A., Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine, 25(20), 3946-3954, 2007 –
114. Lajavardi, L., Bochot, A., Camelo, S., Goldenberg, B., Naud, M.C., Behar-Cohen, F., Fattal, E., de Kozak, Y., Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes. Investigative Ophthalmology & Visual Science, 48(7), 3230-3238, 2007 –
113. Gervelas, C., Serandour, A.L., Geiger, S., Grillon, G., Fritsch, P., Taulelle, C., Le Gall, B., Benech, H., Deverre, J.R., Fattal, E., Tsapis, N., Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium. Journal of Controlled Release, 118(1), 78-86, 2007 –
112. Dribek, M., Le Potier, I., Rodrigues, A., Pallandre, A., Fattal, E., Taverna, M., Determination of binding constants of vasoactive intestinal peptide to poly(amidoamine) dendrimers designed for drug delivery using ACE. Electrophoresis, 28(13), 2191-2200, 2007 –
111. Camelo, S., Lajavardi, L., Bochot, A., Goldenberg, B., Naud, M.C., Fattal, E., Behar-Cohen, F., de Kozak, Y., Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats. Molecular Vision, 13(256), 2263-2274, 2007 –
110. Bochot, A., Trichard, L., Le Bas, G., Alphandary, H., Grossiord, J.L., Duchene, D., Fattal, E., alpha-Cyclodextrin/oil beads: An innovative self-assembling system. International Journal of Pharmaceutics, 339(1-2), 121-129, 2007 –
109. Fattal, E., Bochot, A., Antisense oligonucleotides, aptamers and SiRNA: promises for the treatment of ocular diseases. Archivos de la Sociedad Espanola de Oftalmologia, 81(1), 3-4, 5-6, 2006 –
108. Gomes dos Santos, A.L., Bochot, A., Tsapis, N., Artzner, F., Bejjani, R.A., Thillaye-Goldenberg, B., de Kozak, Y., Fattal, E., Behar-Cohen, F., Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGFbeta-2 therapy. Pharmaceutical Research, 23(4), 770-781, 2006 –
107. Gomes dos Santos, A.L., Bochot, A., Doyle, A., Tsapis, N., Siepmann, J., Siepmann, F., Schmaler, J., Besnard, M., Behar-Cohen, F., Fattal, E., Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. Journal of Controlled Release, 112(3), 369-381, 2006 –
106. Toub, N., Malvy, C., Fattal, E., Couvreur, P., Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomedicine & Pharmacotherapy, 60(9), 607-620, 2006 –
105. Toub, N., Bertrand, J.R., Tamaddon, A., Elhamess, H., Hillaireau, H., Maksimenko, A., Maccario, J., Malvy, C., Fattal, E., Couvreur, P., Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. Pharmaceutical Research, 23(5), 892-900, 2006 –
104. Toub, N., Bertrand, J.R., Malvy, C., Fattal, E., Couvreur, P., Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing’s sarcoma model. Oligonucleotides, 16(2), 158-168, 2006 –
103. Shakweh, M., Fattal, E., Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide. Journal of Nanoscience and Nanotechnology, 6(9-10), 2811-2820, 2006 –
102. Pisani, E., Tsapis, N., Paris, J., Nicolas, V., Cattel, L., Fattal, E., Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 22(9), 4397-4402, 2006 –
101. Phan, G., Le Gall, B., Grillon, G., Rouit, E., Fouillit, M., Benech, H., Fattal, E., Deverre, J.R., Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes. Biochimie, 88(11), 1843-1849, 2006 –
100. Phan, G., Le Gall, B., Deverre, J.R., Fattal, E., Benech, H., Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats. Pharmaceutical Research, 23(9), 2030-2035, 2006 –
99. Maillard, S., Gauduchon, J., Marsaud, V., Gouilleux, F., Connault, E., Opolon, P., Fattal, E., Sola, B., Renoir, J.M., Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma. Journal of Steroid Biochemistry and Molecular Biology, 100(1-3), 67-78, 2006 –
98. Fattal, E., Bochot, A., Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Advanced Drug Delivery Reviews, 58(11), 1203-1223, 2006 –
97. Desire, L., Mysiakine, E., Bonnafous, D., Couvreur, P., Sagodira, S., Breton, P., Fattal, E., Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers. Biomaterials, 27(12), 2609-2620, 2006 –
96. Bourgeois, S., Gernet, M., Pradeau, D., Andremont, A., Fattal, E., Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads. International Journal of Pharmaceutics, 324(1), 2-9, 2006-
95. Bourgeois, S., Harvey, R.D., Fattal, E., Polymer colon drug delivery systems and their applications to peptides, proteins and nucleic acids. American Journal of Drug Delivery, 3(3), 171-204, 2005 –
94. Harvey, R.D., Bourgeois, S., Pietzonka, L., Desire, L., Fattal, E., Microencapsulation of nanoparticulate complexes of DNA with cationic lipids and polymers in pectin beads for targeted gene delivery. Nanobiotechnology, 1(1), 71-82, 2005 –
93. Gomes Dos Santos, A.L., Bochot, A., Fattal, E., Intraocular delivery of oligonucleotides. Current Pharmaceutical Biotechnology, 6(1), 7-15, 2005 –
92. Ungaro, F., De Rosa, G., Quaglia, F., Fattal, E., La Rotonda, M.I., Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: potential of spray-drying technique. Journal of Drug Delivery Science and Technology, 15(2), 137-143, 2005 –
91. Toub, N., Angiari, C., Eboue, D., Fattal, E., Tenu, J.P., Le Doan, T., Couvreur, P., Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate). Journal of Controlled Release, 106(1-2), 209-213, 2005 –
90. Shakweh, M., Besnard, M., Nicolas, V., Fattal, E., Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer’s patches in mice. European Journal of Pharmaceutics and Biopharmaceutics, 61(1-2), 1-13, 2005 –
89. Phan, G., Herbet, A., Cholet, S., Benech, H., Deverre, J.R., Fattal, E., Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. Journal of Controlled Release, 110(1), 177-188, 2005 –
88. Maillard, S., Ameller, T., Gauduchon, J., Gougelet, A., Gouilleux, F., Legrand, P., Marsaud, V., Fattal, E., Sola, B., Renoir, J.M., Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma. Journal of Steroid Biochemistry and Molecular Biology, 94(1-3), 111-121, 2005 –
87. Maignien, T., Shakweh, M., Calvo, P., Marce, D., Sales, N., Fattal, E., Deslys, J.P., Couvreur, P., Lasmezas, C.I., Role of gut macrophages in mice orally contaminated with scrapie or BSE. International Journal of Pharmaceutics, 298(2), 293-304, 2005 –
86. Lavisse, S., Paci, A., Rouffiac, V., Adotevi, C., Opolon, P., Peronneau, P., Bourget, P., Roche, A., Perricaudet, M., Fattal, E., Lassau, N., In vitro echogenicity characterization of poly lactide-coglycolide (PLGA) microparticles and preliminary in vivo ultrasound enhancement study for ultrasound contrast agent application. Investigative Radiology, 40(8), 536-544, 2005 –
85. Bourgeois, S., Laham, A., Besnard, M., Andremont, A., Fattal, E., In vitro and in vivo evaluation of pectin beads for the colon delivery of beta-lactamases. Journal of Drug Targeting, 13(5), 277-284, 2005 –
84. Boulmedarat, L., Piel, G., Bochot, A., Lesieur, S., Delattre, L., Fattal, E., Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmaceutical Research, 22(6), 962-971, 2005 –
83. Boulmedarat, L., Bochot, A., Lesieur, S., Fattal, E., Evaluation of buccal methyl-beta-cyclodextrin toxicity on human oral epithelial cell culture model. Journal of Pharmaceutical Sciences, 94(6), 1300-1309, 2005 –
82. Shakweh, M., Ponchel, G., Fattal, E., Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery. Expert Opinion on Drug Delivery, 1(1), 141-163, 2004 –
81. Phan, G., Ramounet-Le Gall, B., Manceau, J., Fanet, M., Benech, H., Fritsch, P., Fattal, E., Deverre, J.R., Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats. International Journal of Radiation Biology, 80(6), 413-422, 2004 –
80. Fattal, E., De Rosa, G., Bochot, A., Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids. International Journal of Pharmaceutics, 277(1-2), 25-30, 2004 –
79. Fattal, E., Couvreur, P., Dubernet, C., “Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Advanced Drug Delivery Reviews, 56(7), 931-946, 2004-
78. Quaglia, F., De Rosa, G., Granata, E., Ungaro, F., Fattal, E., Immacolata La Rotonda, M., Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. Journal of Controlled Release, 86(2-3), 267-278, 2003-
77. Maksimenko, A., Lambert, G., Bertrand, J.R., Fattal, E., Couvreur, P., Malvy, C., Therapeutic potentialities of EWS-Fli-1 mRNA-targeted vectorized antisense oligonucleotides. Annals of the New York Academy of Sciences, 100272-77, 2003 –
76. Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., Couvreur, P., Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews, 55(4), 519-548, 2003 –
75. Maksimenko, A., Malvy, C., Lambert, G., Bertrand, J.R., Fattal, E., Maccario, J., Couvreur, P., Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies. Pharmaceutical Research, 20(10), 1565-1567, 2003 –
74. De Rosa, G., Quaglia, F., Bochot, A., Ungaro, F., Fattal, E., Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres. Biomacromolecules, 4(3), 529-536, 2003 –
73. De Rosa, G., Bochot, A., Quaglia, F., Besnard, M., Fattal, E., A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes. International Journal of Pharmaceutics, 254(1), 89-93, 2003 –
72. Boulmedarat, L., Grossiord, J.L., Fattal, E., Bochot, A., Influence of methyl-beta-cyclodextrin and liposomes on rheological properties of Carbopol (R) 974P NF gels. International Journal of Pharmaceutics, 254(1), 59-64, 2003 –
71. De Rosa, G., Quaglia, F., La Rotonda, M., Besnard, M., Fattal, E., Biodegradable microparticles for the controlled delivery of oligonucleotides. International Journal of Pharmaceutics, 242(1-2), 225-228, 2002 –
70. Fattal, E., Pecquet, S., Couvreur, P., Andremont, A., Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens. International Journal of Pharmaceutics, 242(1-2), 15-24, 2002 –
69. De Rosa, G., Quaglia, F., La Rotonda, M.I., Appel, M., Alphandary, H., Fattal, E., Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. Journal of Pharmaceutical Sciences, 91(3), 790-799, 2002 –
68. Couvreur, P., Barratt, G., Fattal, E., Legrand, P., Vauthier, C., Nanocapsule technology: A review. Critical Reviews in Therapeutic Drug Carrier Systems, 19(2), 99-134, 2002 –
67. Bochot, A., Fattal, E., Boutet, V., Deverre, J.R., Jeanny, J.C., Chacun, H., Couvreur, P., Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. Investigative Ophthalmology & Visual Science, 43(1), 253-259, 2002 –
66. Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., Fattal, E., Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. International Journal of Pharmaceutics, 214(1-2), 31-35, 2001 –
65. Le Visage, C., Quaglia, F., Dreux, M., Ounnar, S., Breton, P., Bru, N., Couvreur, P., Fattal, E., Novel microparticulate system made of poly(methylidene malonate 2.1.2). Biomaterials, 22(16), 2229-2238, 2001-
64. Le Visage, C., Couvreur, P., Passirani, C., Breton, P., Bru, N., Fattal, E., Influence of a non-ionic poloxamer surfactant, Pluronic F68, on protein release from poly(methylidene malonate 2.1.2) microparticles in simulated gastric and intestinal media. STP Pharma Sciences, 11(5), 377-383, 2001.
63. Le Visage, C., Couvreur, P., Mysiakine, E., Breton, P., Bru, N., Fattal, E., In vitro and in vivo evaluation of poly(methylidene malonate 2.1.2) microparticles behavior for oral administration. Journal of Drug Targeting, 9(2), 141-153, 2001 –
62. Le Potier, I., Taverna, M., Fattal, E., Benzaki, J., Chevalier, M., Ferrier, D., Performance evaluation of capillary surface treatments for peptide mapping by capillary zone electrophoresis. Chromatographia, 53(9-10), 563-570, 2001 –
61. Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A., Couvreur, P., Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. International Journal of Pharmaceutics, 214(1-2), 13-16, 2001 –
60. Lambert, G., Fattal, E., Couvreur, P., Nanoparticulate systems for the delivery of antisense oligonucleotides. Advanced Drug Delivery Reviews, 47(1), 99-112, 2001 –
59. Fattal, E., Dubernet, C., Couvreur, P., Liposome-based formulations for the delivery of oligonucleotides. STP Pharma Science, 11(1), 31-44, 2001.
58. De Oliveira, M.C., Dubernet, C., Paternostre, M., Fattal, E., Couvreur, P., Ollivon, M., pH-sensitive liposomes as a carrier for oligonucleotides (ODN): development of a new methodology to follow physicochemical changes along with pH of native and ODN loaded liposomes. STP Pharma Science, 11(1), 103-107, 2001.
57. Calvo, P., Gouritin, B., Chacun, H., Desmaele, D., D’Angelo, J., Noel, J.P., Georgin, D., Fattal, E., Andreux, J.P., Couvreur, P., Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharmaceutical Research, 18(8), 1157-1166, 2001 –
56. Trolle, S., Chachaty, E., Kassis-Chikhani, N., Wang, C., Fattal, E., Couvreur, P., Diamond, B., Alonso, J., Andremont, A., Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with streptococcus pneumoniae. Vaccine, 18(26), 2991-2998, 2000 –
55. Pecquet, S., Leo, E., Fritsche, R., Pfeifer, A., Couvreur, P., Fattal, E., Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres. Vaccine, 18(13), 1196-1202, 2000 –
54. Neveux, N., De Bandt, J.P., Fattal, E., Hannoun, L., Poupon, R., Chaumeil, J.C., Delattre, J., Cynober, L.A., Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphate. Journal of Hepatology, 33(1), 68-75, 2000 –
53. Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A., Couvreur, P., Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharmaceutical Research, 17(6), 707-714, 2000 –
52. Lambert, G., Bertrand, J.R., Fattal, E., Subra, F., Pinto-Alphandary, H., Malvy, C., Auclair, C., Couvreur, P., EWS Fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice. Biochemical and Biophysical Research Communications, 279(2), 401-406, 2000 –
51. De Oliveira, M.C., Boutet, V., Fattal, E., Boquet, D., Grognet, J.M., Couvreur, P., Deverre, J.R., Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice. Life Sciences, 67(13), 1625-1637, 2000  –
50. Bochot, A., Couvreur, P., Fattal, E., Intravitreal administration of antisense oligonucleotides: Potential of liposomal delivery. Progress in Retinal and Eye Research, 19(2), 131-147, 2000 –
49. Trolle, S., Caudron, E., Leo, E., Couvreur, P., Andremont, A., Fattal, E., In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin. International Journal of Pharmaceutics, 183(1), 73-79, 1999 –
48. Rojas, J., Pinto-Alphandary, H., Leo, E., Pecquet, S., Couvreur, P., Gulik, A., Fattal, E., A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres. Pharmaceutical Research, 16(2), 255-260, 1999 –
47. Rojas, J., Pinto-Alphandary, H., Leo, E., Pecquet, S., Couvreur, P., Fattal, E., Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. International Journal of Pharmaceutics, 183(1), 67-71, 1999 –
46. Peracchia, M.T., Fattal, E., Desmaele, D., Besnard, M., Noel, J.P., Gomis, J.M., Appel, M., d’Angelo, J., Couvreur, P., Stealth (R) PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. Journal of Controlled Release, 60(1), 121-128, 1999 –
45. Fattal, E., Delattre, J., Dubernet, C., Couvreur, P., Liposomes for the delivery of nucleotides and oligonucleotides. STP Pharma Science, 9(5), 383-390, 1999.
44. Aynie, I., Vauthier, C., Chacun, H., Fattal, E., Couvreur, P., Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense & Nucleic Acid Drug Development, 9(3), 301-312, 1999 –
43. Trolle, S., Andremont, A., Fattal, E., Towards a multipurpose mucosal vaccination using phosphorylcholine as a unique antigen? STP Pharma Sciences, 8(1), 19-30, 1998.
42. Skiba-Lahiani, M., Skiba, M., Nikas, G., Auger, J., Fattal, E., Delattre, J., Courtot, A.M., Interaction between PC12 liposomes encapsulating ATP and human spermatozoa. International Journal of Pharmaceutics, 172(1-2), 147-159, 1998 –
41. Leo, E., Pecquet, S., Rojas, J., Couvreur, P., Fattal, E., Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. Journal of Microencapsulation, 15(4), 421-430, 1998 –
40. Lambert, G., Fattal, E., Brehier, A., Feger, J., Couvreur, P., Effect of polyisobutylcyanoacrylate nanoparticles and Lipofectin (R) loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells. Biochimie, 80(12), 969-976, 1998 –
39. Fattal, E., Vauthier, C., Aynie, I., Nakada, Y., Lambert, G., Malvy, C., Couvreur, P., Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Journal of Controlled Release, 53(1-3), 137-143, 1998 –
38. De Oliveira, M.C., Fattal, E., Couvreur, P., Lesieur, P., Bourgaux, C., Ollivon, M., Dubernet, C., pH-Sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. Biochimica et Biophysica Acta-Biomembranes, 1372(2), 301-310, 1998 –
37. Bochot, A., Mashhour, B., Puisieux, F., Couvreur, P., Fattal, E., Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms. Journal of Drug Targeting, 6(4), 309-313, 1998 –
36. Bochot, A., Fattal, E., Gulik, A., Couarraze, G., Couvreur, P., Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides. Pharmaceutical Research, 15(9), 1364-1369, 1998 –
35. Bochot, A., Fattal, E., Grossiord, J.L., Puisieux, F., Couvreur, P., Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. International Journal of Pharmaceutics, 162(1-2), 119-127, 1998 –
34. Allaoui-Attarki, K., Fattal, E., Pecquet, S., Trolle, S., Chachaty, E., Couvreur, P., Andremont, A., Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres. Vaccine, 16(7), 685-691, 1998 –
33. Couvreur, P., Fattal, E., Malvy, C., Dubernet, C., pH-sensitive liposomes: an intelligent system for the delivery of antisense oligonucleotides. Journal of Liposome Research, 7(1), 1-18, 1997 –
32. Fernandez-Urrusuno, R., Fattal, E., Feger, J., Couvreur, P., Therond, P., Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials, 18(6), 511-517, 1997 –
31. Quintilio, W., Sato, R.A., Da Silveira, A.M., Barratt, G., Fattal, E., BuenodaCosta, M.H., Microquantification of proteins with low chromophore content. Biotechnology Techniques, 11(9), 697-700, 1997 –
30. De Oliveira, M.C., Fattal, E., Ropert, C., Malvy, C., Couvreur, P., Delivery of antisense oligonucleotides by means of pH-sensitive liposomes. Journal of Controlled Release, 48(2-3), 179-184, 1997 –
29. Couvreur, P., BlancoPrieto, M.J., Puisieux, F., Roques, B., Fattal, E., Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Advanced Drug Delivery Reviews, 28(1), 85-96, 1997 –
28. Blanco-Prieto, M.J., Fattal, E., Gulik, A., Dedieu, J.C., Roques, B.P., Couvreur, P., Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method. Journal of Controlled Release, 43(1), 81-87, 1997 –
27. Allaoui-Attarki, K., Pecquet, S., Fattal, E., Trolle, S., Chachaty, E., Couvreur, P., Andremont, A., Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infection and Immunity, 65(3), 853-857, 1997 –
26. Brazeau, G.A., Sciame, M., al-Suwayeh, S.A., Fattal, E., Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model. Pharmaceutical Development and Technology, 1(3), 279-283, 1996 –
25. Ramaldes, G.A., Fattal, E., Puisieux, F., Ollivon, M., Solubilization kinetics of phospholipid vesicles by sodium taurocholate. Colloids and Surfaces B-Biointerfaces, 6(6), 363-371, 1996 –
24. Ramaldes, G.A., Deverre, J.R., Grognet, J.M., Puisieux, F., Fattal, E., Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin. International Journal of Pharmaceutics, 143(1), 1-11, 1996 –
23. Nakada, Y., Fattal, E., Foulquier, M., Couvreur, P., Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharmaceutical Research, 13(1), 38-43, 1996 –
22. Fernandez-Urrusuno, R., Fattal, E., Rodrigues, J.M., Feger, J., Bedossa, P., Couvreur, P., Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. Journal of Biomedical Materials Research, 31(3), 401-408, 1996 –<401::AID-JBM15>3.0.CO;2-L
21. Blanco-Prieto, M.J., Leo, E., Delie, F., Gulik, A., Couvreur, P., Fattal, E., Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method. Pharmaceutical Research, 13(7), 1127-1129, 1996 –
20. Blanco-Prieto, M.J., Durieux, C., Dauge, V., Fattal, E., Couvreur, P., Roques, B.P., Slow delivery of the selective cholecystokinin agonist pBC 264 into the rat nucleus accumbens using microspheres. Journal of Neurochemistry, 67(6), 2417-2424, 1996 –
19. Aynie, I., Vauthier, C., Foulquier, M., Malvy, C., Fattal, E., Couvreur, P., Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier. Analytical Biochemistry, 240(2), 202-209, 1996 –
18. Fernandez-Urrusuno, R., Fattal, E., Porquet, D., Feger, J., Couvreur, P., Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. Toxicology and Applied Pharmacology, 130(2), 272-279, 1995 –
17. Fernandez-Urrusuno, R., Fattal, E., Porquet, D., Feger, J., Couvreur, P., Influence of surface properties on the inflammatory response to polymeric nanoparticles. Pharmaceutical Research, 12(9), 1385-1387, 1995 –
16. Skiba-Lahiani, M., Auger, J., Terribile, J., Fattal, E., Delattre, J., Puisieux, F., Jouannet, P., Stimulation of movement and acrosome reaction of human spermatozoa by PC12 liposomes encapsulating ATP. International Journal of Andrology, 18(6), 287-294, 1995 –
15. Puisieux, F., Fattal, E., Lahiani, M., Auger, J., Jouannet, P., Couvreur, P., Delattre, J., Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP). in vitro and in vivo studies. Journal of Drug Targeting, 2(5), 443-448, 1994 –
14. Fattal, E., Nir, S., Parente, R.A., Szoka, F.C., Jr., Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry, 33(21), 6721-6731, 1994 –
13. Blanco-Prieto, M.J., Delie, F., Fattal, E., Tartar, A., Puisieux, F., Gulik, A., Couvreur, P., Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (W(1)/O)W(2) emulsion solvent evaporation method. International Journal of Pharmaceutics, 111(2), 137-145, 1994 –
12. Maaßen, S., Fattal, E., Muller, R.H., Couvreur, P., Cell cultures for the assessment of toxicity and uptake of polymeric particulate drug carriers. STP Pharma Science, 3(1), 11-22, 1993.
11. Puisieux, F., Fattal, E., Couvreur, P., Rossignol, P., Delattre, J., Liposomes their fate in-vivo and their possible therapeutic use (iv route) – efficiency of liposome-entrapped ATP in cerebral-ischemia. Phosphorus Sulfur and Silicon and the Related Elements, 77(1-4), 661-664, 1993 –
10. Couvreur, P., Fattal, E., Alphandary, H.P., F., Andremont, A., Intracelllular targeting of antibiotics by means of biodegradable nanoparticles. Journal of Controlled Release, 19F259-268, 1992 –
9. Fattal, E., Rojas, J., Roblot-Treupel, L., Andremont, A., Couvreur, P., Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. Journal of Microencapsulation, 8(1), 29-36, 1991 –
8. Fattal, E., Rojas, J., Youssef, M., Couvreur, P., Andremont, A., Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrobial Agents and Chemotherapy, 35(4), 770-772, 1991 – https://doi.org10.1128/AAC.35.4.770
7. Couvreur, P., Fattal, E., Andremont, A., Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharmaceutical Research, 8(9), 1079-1086, 1991 –
6. Seijo, B., Fattal, E., Roblot-Treupel, L., Couvreur, P., Design of nanoparticles sizing less than  50 nm: preparation, characterization and drug loading. International Journal of Pharmaceutics, 62(1), 1-7, 1990 –
5. Fattal, E., Youssef, M., Couvreur, P., Andremont, A., Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrobial Agents and Chemotherapy, 33(9), 1540-1543, 1989 –
4. Laham, A., Claperon, N., Durussel, J.J., Fattal, E., Delattre, J., Puisieux, F., Couvreur, P., Rossignol, P., Liposomally entrapped adenosine triphosphate. Improved efficiency against experimental brain ischaemia in the rat. Journal of Chromatography, 440455-458, 1988 –
3. Youssef, M., Fattal, E., Alonso, M.J., Roblot-Treupel, L., Sauzieres, J., Tancrede, C., Omnes, A., Couvreur, P., Andremont, A., Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice. Antimicrobial Agents and Chemotherapy, 32(8), 1204-1207, 1988 –
2. Laham, A., Claperon, N., Durussel, J.J., Fattal, E., Delattre, J., Puisieux, F., Couvreur, P., Rossignol, P., Intracarotidal administration of liposomally-entrapped ATP: improved efficiency against experimental brain ischemia. Pharmacological Research Communications, 20(8), 699-705, 1988 –
1. Laham, A., Claperon, N., Durussel, J.J., Fattal, E., Delattre, J., Puisieux, F., Couvreur, P., Rossignol, P., Liposomally-entrapped ATP: improved efficiency against experimental brain ischemia in the rat. Life Sciences, 40(20), 2011-2016, 1987 –